Arcturus Therapeutics Ltd.
company.status.inactiveCIK 1566049fmd_1P7R82K45184C9KVY2M8ZME6ABManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Mar 31, 2019, 17 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | – | – | 6 | 20 | 13 | 16 |
| Net interest income | – | – | (0) | (0) | (0) | 0 | 0 | 1 | – | – |
| Research and development | – | – | 2 | 1 | 7 | 25 | 5 | 18 | 16 | 17 |
| Total operating expenses | – | – | – | – | – | – | 8 | 21 | 23 | 38 |
| Operating income | – | – | (4) | (2) | (10) | (33) | (2) | (1) | (10) | (22) |
| Interest expense | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – |
| Interest and investment income | – | – | 0 | 0 | 0 | 0 | 0 | 1 | – | – |
| Other non-operating income (expense) | – | – | – | – | – | – | 0 | (1) | (0) | 0 |
| Income before taxes | – | – | – | – | (10) | (33) | (2) | (2) | (11) | (22) |
| Income tax expense | – | – | – | 0 | 0 | (0) | 0 | 0 | 0 | – |
| Net income from continuing operations | – | – | – | – | (11) | (33) | (2) | (2) | (11) | – |
| Net income | (1) | (1) | (4) | (2) | (11) | (33) | (2) | (2) | (11) | (22) |
| Net income to common shareholders | – | – | (4) | (2) | (11) | – | – | – | – | – |